Studies Toward A Genetic Understanding of Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999023
Summary
Although elevated intraocular pressure (IOP) is a hallmark of glaucoma, not all people with high IOP develop glaucoma. Thus, other factors contribute to the disease, and Dr. John is investigating whether genes that cause IOP interact with other glaucoma genes that affect the optic nerve and retina. Using mouse genetics, Dr. John has found inbred lines of mice in which differences in IOP are inherited. He is working to obtain a higher-resolution genetic map to aid in identifying the genes causing high IOP. In addition, Dr. John has found that genes from one mouse strain can decrease the severity of glaucoma in a recipient mouse strain. He is extending this project by trying to identify these glaucoma modifier genes. Identifying modifier genes in humans is very difficult, but if these genes can be identified in mice, then their role in human glaucoma may be more easily determined. This information could help identify people who are at risk for developing the disease. This is a further development of Dr. John’s previous study.
Related Grants
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute